- Home
- MAX vs HUMA Comparison
MAX vs HUMA Comparison
Compare MAX & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAX
- HUMA
- Stock Information
- Founded
- MAX 2014
- HUMA 2004
- Country
- MAX United States
- HUMA United States
- Employees
- MAX N/A
- HUMA N/A
- Industry
- MAX Industrial Machinery/Components
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- MAX Industrials
- HUMA Health Care
- Exchange
- MAX Nasdaq
- HUMA Nasdaq
- Market Cap
- MAX 604.9M
- HUMA 584.8M
- IPO Year
- MAX 2020
- HUMA N/A
- Fundamental
- Price
- MAX $11.77
- HUMA $4.37
- Analyst Decision
- MAX Buy
- HUMA Strong Buy
- Analyst Count
- MAX 8
- HUMA 7
- Target Price
- MAX $22.00
- HUMA $13.43
- AVG Volume (30 Days)
- MAX 375.8K
- HUMA 2.4M
- Earning Date
- MAX 02-24-2025
- HUMA 03-21-2025
- Dividend Yield
- MAX N/A
- HUMA N/A
- EPS Growth
- MAX N/A
- HUMA N/A
- EPS
- MAX 0.19
- HUMA N/A
- Revenue
- MAX $681,230,000.00
- HUMA N/A
- Revenue This Year
- MAX $122.48
- HUMA N/A
- Revenue Next Year
- MAX $32.24
- HUMA $4,344.68
- P/E Ratio
- MAX $62.34
- HUMA N/A
- Revenue Growth
- MAX 72.47
- HUMA N/A
- 52 Week Low
- MAX $10.21
- HUMA $2.81
- 52 Week High
- MAX $25.78
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- MAX 55.43
- HUMA 45.11
- Support Level
- MAX $11.02
- HUMA $4.20
- Resistance Level
- MAX $11.73
- HUMA $4.78
- Average True Range (ATR)
- MAX 0.45
- HUMA 0.28
- MACD
- MAX 0.09
- HUMA -0.02
- Stochastic Oscillator
- MAX 75.00
- HUMA 42.17
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.